Share this Post!

The CNN Philippines recently conducted an exclusive interview with the Food and Drug Administration (FDA) to discuss the commercial approval of Pfizer’s Bivalent COVID-19 Vaccine. Director General Dr. Samuel A. Zacate took part in the interview, aiming to provide the public with a comprehensive understanding of the vaccine while addressing their concerns.

Various aspects of the vaccine were covered during the interview such as its approval, stock availability, storage requirements, purchasing procedures, and the vaccine’s pricing and availability. The FDA highlighted specific conditions and considerations that must be followed when administering the vaccine, emphasizing the importance of healthcare professionals and the public being aware of these limitations and adhering to the provided guidelines.

The FDA’s implementation of these limitations is essential to safeguard the well-being of individuals and address any potential risks or uncertainties associated with the vaccine. By upholding these measures, the FDA aims to maintain the safety, efficacy, and quality of the approved vaccine and to mitigate any potential adverse effects.

Furthermore, the interview also brought attention to the issue of unnotified “Lato-Lato”. The FDA issued Advisories cautioning the general public on the use of such unnotified health products.
Watch the full interview here:
#FDA #FDAPhilippines #Educate #Regulate #Monitor

See more: